Parameters in the prediction of the sensitivity of parathyroid scanning

Clinical Nuclear Medicine

Volumn 31, Issue 11, 2006, Pages 679-682

  Siegel, Alan ^a   Alvarado, Michael ^b   Barth Jr , Richard J ^a   Brady, Matthew ^c   Lewis, Jill ^a  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adenoma; Parathyroid; Scintigraphy

Indexed keywords

BIOLOGICAL MARKER; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PARATHYROID HORMONE; PERTECHNETIC ACID TC 99M; TRACER;

CANCER DIAGNOSIS; CANCER SURGERY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DISEASE MARKER; HUMAN; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; PARATHYROID ADENOMA; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROID SCINTISCANNING; PREDICTION; PRIMARY HYPERPARATHYROIDISM; RETROSPECTIVE STUDY; REVIEW; STATISTICAL SIGNIFICANCE;

ADENOMA; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; HUMANS; IMAGE ENHANCEMENT; PARATHYROID HORMONE; PARATHYROID NEOPLASMS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 33750339230     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rlu.0000242212.23936.a7     Document Type: Review

References (20)

1. Wermers RA, Khosla S, Atkinson EJ, et al. The rise and fall of primary hyperparathyroidism: a population-based study in Rochester, Minnesota, 1965-1992. Ann Intern Med. 1997;126:433-440.
2. Davies M. Hyperparathyroidism. In: Rakel RE, Bope ET, eds. Conn's Current Therapy 2003, 55th ed. Philadelphia: WB Saunders; 2003:699-704.
3. Cotran RS, Kumar V, Collins T. Robbins Pathological Basis of Disease, 6th ed. Philadelphia: WB Saunders; 1999:1148-1151.
4. Bilezikian JP, Silverberg SJ. Clinical practice. Asymptomatic primary hyperparathyroidism. N Engl J Med. 2004;350:1746-1751.
5. Hindie E, Melliere D, Perlemuter L, et al. Primary hyperparathyroidism: higher success rate of first surgery after preoperative Tc-99m sestamibi-I-123 subtraction scanning. Radiology. 1997;204:221-228.
6. Majors JD, Burke GJ, Mansberger AR Jr, et al. Technetium Tc 99m sestamibi scan for localizing abnormal parathyroid glands after previous neck operations: preliminary experience in reoperative cases. South Med J. 1995;88:327-330.
7. Casas AT, Burke GJ, Mansberger AR Jr, et al. Impact of technetium-99m-sestamibi localization on operative time and success of operations for primary hyperparathyroidism. Am Surg. 1994;60:12-16; discussion 16-17.
8. Taillefer R, Boucher Y, Potvin C, et al. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m-sestamibi (double-phase study). J Nucl Med. 1992;33:1801-1807.
9. Wei JP, Burke GJ, Mansberger AR Jr. Prospective evaluation of the efficacy of technetium 99m sestamibi and iodine 123 radionuclide imaging of abnormal parathyroid glands. Surgery. 1992;112:1111-1116; discussion 1116-1117.
10. O'Doherty MJ, Kettle AG, Wells P, et al. Parathyroid imaging with technetium-99m-sestamibi: preoperative localization and tissue uptake studies. J Nucl Med. 1992;33:313-318.
11. McBiles M, Lambert AT, Cote MG, et al. Sestamibi parathyroid imaging. Semin Nucl Med. 1995;25:221-234.
12. Hindie E, Melliere D, Simon D, et al. Primary hyperparathyroidism: is technetium 99m-Sestamibi/iodine-123 subtraction scanning the best procedure to locate enlarged glands before surgery? J Clin Endocrinol Metab. 1995;80:302-307.
13. Neumann DR, Esselstyn CB Jr, Go RT, et al. Comparison of double-phase 99mTc-sestamibi with 123I-99mTc-sestamibi subtraction SPECT in hyperparathyroidism. AJR Am J Roentgenol. 1997;169:1671-1674.
14. Perez-Monte J, Brown M, Shah A, et al. Parathyroid adenomas: accurate detection and localizaton with Tc-99m sestamibi SPECT. Radiology. 1996;201:85-91.
15. Ishibashi M, Nishida H, Hiromatsu Y, et al. Comparison of technetium-99m-MIBI, technetium-99m-tetrofosmin, ultrasound and MRI for localization of abnormal parathyroid glands. J Nucl Med. 1998;39:320-324.
16. Westreich RW, Brandwein M, Mechanick JI, et al. Preoperative parathyroid localization: correlating false-negative technetium 99m sestamibi scans with parathyroid disease. Laryngoscope. 2003;113:567-572.
17. Bindlish V, Freeman JL, Witterick IJ, et al. Correlation of biochemical parameters with single parathyroid adenoma weight and volume. Head Neck. 2002;24:1000-1003.
18. Mozes G, Curlee KJ, Rowland CM, et al. The predictive value of laboratory findings in patients with primary hyperparathyroidism. J Am Coll Surg. 2002;194:126-130.
19. Saxe AW, Lincenberg S, Hamburger SW. Can the volume of abnormal parathyroid tissue be predicted by preoperative biochemical measurement? Surgery. 1987;102:840-845.
20. Broulik PD, Stepan JJ, Hradec E, et al. Correlation between mass of parathyroid adenoma and biochemical indicators of bone turnover in patients with primary hyperparathyroidism. Exp Clin Endocrinol. 1986;88:360-364.